| P50 | author | Valentina Fainardi | Q55094096 |
| | Sejal Saglani | Q42608323 |
| P2860 | cites work | A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients. | Q53979709 |
| | Defective IL-10 expression and in vitro steroid-induced IL-17A in paediatric severe therapy-resistant asthma. | Q54426683 |
| | Non-eosinophilic cor ticosteroid unresponsive asthma | Q55094026 |
| | The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma | Q57892223 |
| | In utero cigarette smoke exposure impairs somatic and lung growth in BALB/c mice | Q58385196 |
| | Fungal allergy in asthma-state of the art and research needs | Q22001138 |
| | Interleukin-10 and the interleukin-10 receptor | Q24290912 |
| | A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations | Q24307696 |
| | Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice | Q24600284 |
| | Asthma across the ages: knowledge gaps in childhood asthma | Q26821787 |
| | The genomic origins of asthma | Q27013204 |
| | Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program | Q30428546 |
| | The molecular phenotype of severe asthma in children. | Q30432832 |
| | Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells | Q33508406 |
| | Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data | Q33685280 |
| | Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations | Q33720547 |
| | Spirometric lung function in school-age children: effect of intrauterine growth retardation and catch-up growth. | Q33821411 |
| | In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma. | Q34120964 |
| | Lebrikizumab treatment in adults with asthma | Q34205683 |
| | IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma | Q34446514 |
| | Age-of-asthma onset as a determinant of different asthma phenotypes in adults: a systematic review and meta-analysis of the literature. | Q34458002 |
| | Respiratory syncytial virus represses glucocorticoid receptor-mediated gene activation | Q34566553 |
| | Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation | Q34580221 |
| | Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma | Q34987105 |
| | Parental smoking and lung function in children: an international study. | Q53259997 |
| | Fungal sensitization in childhood persistent asthma is associated with disease severity. | Q53341453 |
| | IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. | Q34987195 |
| | Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults | Q35023114 |
| | Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis | Q35081904 |
| | Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells | Q35142836 |
| | Lung microbiota promotes tolerance to allergens in neonates via PD-L1. | Q35165937 |
| | Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease | Q35180759 |
| | Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation | Q35190104 |
| | Type 2 inflammation in asthma--present in most, absent in many | Q35322784 |
| | The importance of bacterial and viral infections associated with adult asthma exacerbations in clinical practice | Q35527327 |
| | The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development | Q35599871 |
| | Association of improved air quality with lung development in children | Q35603158 |
| | Early identification of atopy in the prediction of persistent asthma in children | Q35633553 |
| | Noninvasive analysis of the sputum transcriptome discriminates clinical phenotypes of asthma | Q35672591 |
| | Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life | Q35813698 |
| | Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma | Q35855205 |
| | Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology | Q36044280 |
| | Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines | Q36054219 |
| | Genome-wide association study of the age of onset of childhood asthma | Q36069551 |
| | Early growth and adult respiratory function in men and women followed from the fetal period to adulthood | Q36225633 |
| | Management of severe asthma in children | Q36316775 |
| | Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma | Q36316780 |
| | Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma | Q36316785 |
| | Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood | Q36371040 |
| | The link between fungi and severe asthma: a summary of the evidence. | Q36409578 |
| | Airway smooth muscle in bronchial tone, inflammation, and remodeling: basic knowledge to clinical relevance | Q36414879 |
| | Specific patterns of allergic sensitization in early childhood and asthma & rhinitis risk. | Q36570245 |
| | Controversies in the management of preschool viral wheeze | Q36650937 |
| | Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children | Q36915476 |
| | Body mass and glucocorticoid response in asthma. | Q36915488 |
| | Chronic exposure to ambient levels of urban particles affects mouse lung development | Q36915499 |
| | Severe asthma: an expanding and mounting clinical challenge | Q36935177 |
| | Rhinovirus wheezing illness and genetic risk of childhood-onset asthma | Q37128812 |
| | The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma | Q37244199 |
| | Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing | Q37365524 |
| | The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation | Q37524704 |
| | Passive smoking impairs histone deacetylase-2 in children with severe asthma. | Q37553296 |
| | Linkage between smoking and asthma | Q37615478 |
| | Clinical heterogeneity in the severe asthma research program | Q37651783 |
| | Environmental exposures and asthma morbidity in children living in urban neighborhoods | Q37697764 |
| | Cluster analysis and clinical asthma phenotypes. | Q37711387 |
| | WHO universal definition of severe asthma | Q37837401 |
| | Pulmonary immunity during respiratory infections in early life and the development of severe asthma | Q37842564 |
| | Neonatal chlamydial pneumonia induces altered respiratory structure and function lasting into adult life. | Q37850554 |
| | Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology | Q37853685 |
| | Maternal and fetal origins of lung disease in adulthood | Q37978682 |
| | Asthma phenotypes: the evolution from clinical to molecular approaches | Q38007831 |
| | International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma | Q38171268 |
| | Body mass index and the incidence of asthma in children | Q38185540 |
| | Asthma therapy and its effect on airway remodelling. | Q38233318 |
| | Epithelial cytokines and pulmonary allergic inflammation | Q38364242 |
| | Outcomes of childhood asthma to the age of 50 years | Q40218924 |
| | Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells. | Q42213596 |
| | Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial | Q42262026 |
| | Neonatal rhinovirus infection induces mucous metaplasia and airways hyperresponsiveness. | Q42602368 |
| | National Review of Asthma Deaths (NRAD). | Q42975413 |
| | Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples | Q43099470 |
| | Temporal assessment of airway remodeling in severe asthma using quantitative computed tomography. | Q43111808 |
| | Respiratory syncytial virus infection reversed anti-asthma effect of neonatal Bacillus Calmette-Guerin vaccination in BALB/c mice | Q43688145 |
| | Maternal nicotine exposure during gestation and lactation of rats induce microscopic emphysema in the offspring | Q44049875 |
| | Childhood asthma after bacterial colonization of the airway in neonates | Q44570200 |
| | Risk factors of frequent exacerbations in difficult-to-treat asthma | Q44681336 |
| | Eosinophils in the spotlight: Eosinophilic airway inflammation in nonallergic asthma | Q44715380 |
| | Respiratory syncytial virus: a sleeping giant? | Q44816055 |
| | The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production | Q45435028 |
| | Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis | Q45874711 |
| | Maternal smoking during pregnancy induces airway remodelling in mice offspring. | Q46171911 |
| | Effects of early onset asthma and in utero exposure to maternal smoking on childhood lung function | Q46303720 |
| | Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children | Q46664259 |
| | Effects of fetal growth restriction on lung development before and after birth: a morphometric analysis. | Q46756474 |
| | Haplotype associated with low interleukin-10 production in patients with severe asthma | Q47808922 |
| | Childhood infections, the developing immune system, and the origins of asthma. | Q47885783 |
| | Mepolizumab treatment in patients with severe eosinophilic asthma | Q48065984 |
| | The association between childhood asthma and adult chronic obstructive pulmonary disease | Q48118694 |
| | Prognostic value of cluster analysis of severe asthma phenotypes. | Q51071213 |
| | Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. | Q52930916 |
| P433 | issue | 4 | |
| P921 | main subject | asthma | Q35869 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 419-428 | |
| P577 | publication date | 2015-07-15 | |
| P1433 | published in | Expert Review of Respiratory Medicine | Q15754583 |
| P1476 | title | The need to differentiate between adults and children when treating severe asthma | |
| P478 | volume | 9 | |